Atypical pneumonias: therapeutic possibilities
1Hacettepe University School of Medicine, Ankara, Turkey.
International Journal of Antimicrobial Agents
|November 1, 1993
Summary
Atypical pneumonia presents with systemic symptoms and is caused by intracellular pathogens. Treatment involves cell-penetrating antibiotics like macrolides or tetracyclines, with fluoroquinolones as promising alternatives.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Atypical pneumonia syndrome is defined by systemic symptoms, differing from typical respiratory presentations.
- Key causative agents include Mycoplasma, Chlamydia, Legionella, and various respiratory viruses.
- The incidence of these pathogens in community-acquired pneumonias shows significant study-to-study variation.
Purpose of the Study:
- To review the causative agents of atypical pneumonia.
- To outline current and alternative antimicrobial therapies for atypical pneumonia.
- To highlight treatment strategies for specific pathogens like Legionella.
Main Methods:
- Literature review of atypical pneumonia pathogens and treatment guidelines.
- Analysis of antibiotic classes effective against intracellular pathogens.
- Examination of empirical antimicrobial therapy recommendations.
Main Results:
- Intracellular pathogens necessitate antibiotics with cell penetration capabilities.
- Macrolides (e.g., azithromycin) and tetracyclines (e.g., doxycycline) are primary empirical treatments.
- Rifampicin combination therapy and newer fluoroquinolones show promise for severe Legionella cases.
Conclusions:
- Effective atypical pneumonia management requires understanding causative agents and their intracellular nature.
- Macrolides and tetracyclines form the cornerstone of empirical treatment.
- Fluoroquinolones represent a valuable therapeutic option, particularly for Legionella infections.
Related Concept Videos
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.